Daily as of 3 Nov 16:00 ET
- Price
- between the two $9.68 vs 50 $10.49 / 200 $9.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 24 Sep 2026 · projected 12 bars out
NVAX | NovavaxNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.68
+$0.15 (+1.57%)
Novavax (NVAX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $10.08 vs 50 $8.86 / 200 $8.41
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 26 Sep 2022 · projected 28 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $9.68 vs 50 $10.99 / 200 $9.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Sep 2026 bar 1 · projected 27 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 24 Sep 2026 | 🟨Golden flat | daily | 12 bars out | Not tested |
| 11 Sep 2026 | 💀Death flat | daily | 6 bars out | Not tested |
| 10 Sep 2026 | 🟨Golden | 4-hour | 27 bars out | 2 bar cross test |
| 3 Sep 2026 | 🟨Golden flat | daily | 28 bars out | Not tested |
| 27 Aug 2026 | 💀Death flat | daily | 29 bars out | Not tested |
About NVAX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$51.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall